| CNBX Pharmaceuticals Inc. (CNBXD) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | |
| Balance Sheet Date | 2025-Nov-30 | 2025-Aug-31 | 2025-May-31 | 2025-Feb-28 | 2024-Nov-30 | 2024-Aug-31 | 2024-May-31 | 2024-Feb-29 | 2021-Aug-31 | 2021-May-31 | 2021-Feb-28 | 2020-Nov-30 | 2020-Aug-31 | 2020-May-31 | 2020-Feb-29 | 2019-Nov-30 | 2019-Aug-31 | 2019-May-31 | 2019-Feb-28 | 2018-Nov-30 | 2018-Aug-31 | 2018-May-31 | 2018-Feb-28 | 2017-Nov-30 | 2017-Aug-31 | 2017-May-31 | 2017-Feb-28 | 2016-Nov-30 | 2016-Aug-31 | 2016-May-31 | 2016-Feb-29 | 2015-Nov-30 | 2015-Aug-31 | 2015-May-31 | 2015-Feb-28 | 2014-Nov-30 | 2014-Aug-31 | 2014-May-31 | 2014-Feb-28 | ||||||||||
| Fiscal Period | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | ||||||||||
| Operating Cash Flow | (47,408$) | (28,545$) | (52,019$) | (51,664$) | (39,077$) | (48,250$) | 225$ | (71,846$) | 20,517$ | (18,591$) | (581,819$) | (616,117$) | (702,340$) | (592,637$) | (713,959$) | (575,679$) | (723,630$) | (761,687$) | (868,673$) | (818,635$) | (739,337$) | (667,135$) | (621,497$) | (465,624$) | (434,597$) | (452,974$) | (343,467$) | (205,443$) | (167,701$) | (146,956$) | (31,277$) | ||||||||||||||||||
| Investing Cash Flow | 0$ | 94,673$ | (1,196$) | 0$ | 0$ | 0$ | 0$ | 645,968$ | (943$) | 1,133,941$ | 346,336$ | 991,258$ | 815,049$ | 641,160$ | (3,855,704$) | (740,195$) | (1,296,376$) | (700,257$) | (98,265$) | (639,402$) | (4,470$) | (34,695$) | (89,347$) | (1,733$) | 0$ | ||||||||||||||||||||||||
| Purchases of Property and Equipment | 0$ | 0$ | 0$ | 0$ | 0$ | 3,710$ | |||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 40,000$ | 30,008$ | 19,992$ | 80,000$ | 30,000$ | 1,260$ | 1,259$ | 24,993$ | 65,028$ | 14,994$ | 0$ | 1,250,000$ | 1,206,750$ | 0$ | 0$ | 0$ | 0$ | 0$ | (7$) | 0$ | 67,466$ | 7,149,811$ | 500,000$ | (85,000$) | 1,050,000$ | (22,000$) | 555,553$ | 2,917,876$ | 458,500$ | 405,980$ | |||||||||||||||||||
| End Cash Position | 7,703$ | 15,111$ | 13,648$ | 45,675$ | 17,339$ | 26,416$ | 73,406$ | 37,142$ | 81,647$ | 129,696$ | 44,151$ | 47,748$ | 117,515$ | 1,386,472$ | 1,968,291$ | 1,334,409$ | 184,031$ | 777,611$ | 357,629$ | 586,972$ | 319,344$ | 265,982$ | 493,501$ | 5,167,840$ | 6,579,908$ | 1,393,608$ | 2,215,362$ | 2,864,251$ | 2,888,250$ | 1,393,608$ | 3,190,303$ | 567,217$ | 278,151$ | 19,127$ | 88,502$ | 77,397$ | 9,560$ | 25,229$ | 21,551$ | 8,211$ | 32,468$ | 98,768$ | 0$ | 1,076$ | |||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (47,408$) | (28,545$) | (52,019$) | (51,664$) | (39,077$) | (48,250$) | 225$ | (71,846$) | 20,517$ | (18,591$) | (581,819$) | (616,117$) | (702,340$) | (592,637$) | (713,959$) | (575,679$) | (723,630$) | (761,687$) | (868,673$) | (818,635$) | (739,337$) | (667,135$) | (621,497$) | (465,624$) | (434,597$) | (452,974$) | (343,467$) | (205,443$) | (167,701$) | (146,956$) | (31,277$) | ||||||||||||||||||